Research output per year
Research output per year
Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/14 → 31/12/16 |
Funding
- National Health and Medical Research Council (NHMRC) (Australia): A$716,728.00
Research output
- 8 Article
-
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance
Agyeman, A. A., Rogers, K. E., Tait, J. R., Bergen, P. J., Kirkpatrick, C. M., Wallis, S. C., Bulitta, J. B., Paterson, D. L., Lipman, J., Nation, R. L., Roberts, J. A. & Landersdorfer, C. B., Apr 2021, In: Clinical Pharmacology & Therapeutics. 109, 4, p. 1104-1115 12 p.Research output: Contribution to journal › Article › Research › peer-review
17 Citations (Scopus) -
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients
Yadav, R., Bergen, P. J., Rogers, K. E., Kirkpatrick, C. M. J., Wallis, S. C., Huang, Y., Bulitta, J. B., Paterson, D. L., Lipman, J., Nation, R. L., Roberts, J. A. & Landersdorfer, C. B., Jan 2020, In: Antimicrobial Agents and Chemotherapy. 64, 1, 14 p., e01679-19.Research output: Contribution to journal › Article › Research › peer-review
19 Citations (Scopus) -
Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli
Bergen, P. J., Bulitta, J. B., Sime, F. B., Lipman, J., McGregor, M. J., Millen, N., Paterson, D. L., Kirkpatrick, C. M. J., Roberts, J. A. & Landersdorfer, C. B., 1 May 2018, In: Diagnostic Microbiology and Infectious Disease. 91, 1, p. 69-76 8 p.Research output: Contribution to journal › Article › Research › peer-review
4 Citations (Scopus)